000 01453 a2200421 4500
005 20250513041148.0
264 0 _c19950517
008 199505s 0 0 eng d
022 _a0959-8138
024 7 _a10.1136/bmj.310.6983.827
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWeil, J
245 0 0 _aProphylactic aspirin and risk of peptic ulcer bleeding.
_h[electronic resource]
260 _bBMJ (Clinical research ed.)
_cApr 1995
300 _a827-30 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnti-Inflammatory Agents, Non-Steroidal
_xadverse effects
650 0 4 _aAspirin
_xadverse effects
650 0 4 _aCardiovascular Diseases
_xprevention & control
650 0 4 _aCase-Control Studies
650 0 4 _aChemistry, Pharmaceutical
650 0 4 _aDrug Administration Schedule
650 0 4 _aDrug Interactions
650 0 4 _aHospitalization
_xstatistics & numerical data
650 0 4 _aHumans
650 0 4 _aPeptic Ulcer Hemorrhage
_xchemically induced
650 0 4 _aRisk Factors
700 1 _aColin-Jones, D
700 1 _aLangman, M
700 1 _aLawson, D
700 1 _aLogan, R
700 1 _aMurphy, M
700 1 _aRawlins, M
700 1 _aVessey, M
700 1 _aWainwright, P
773 0 _tBMJ (Clinical research ed.)
_gvol. 310
_gno. 6983
_gp. 827-30
856 4 0 _uhttps://doi.org/10.1136/bmj.310.6983.827
_zAvailable from publisher's website
999 _c7711008
_d7711008